180 related articles for article (PubMed ID: 29440639)
1. The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma.
Canovas Nunes S; Manzoni M; Pizzi M; Mandato E; Carrino M; Quotti Tubi L; Zambello R; Adami F; Visentin A; Barilà G; Trentin L; Manni S; Neri A; Semenzato G; Piazza F
Blood Cancer J; 2018 Feb; 8(2):20. PubMed ID: 29440639
[TBL] [Abstract][Full Text] [Related]
2. The RhoU/Wrch1 Rho GTPase gene is a common transcriptional target of both the gp130/STAT3 and Wnt-1 pathways.
Schiavone D; Dewilde S; Vallania F; Turkson J; Di Cunto F; Poli V
Biochem J; 2009 Jun; 421(2):283-92. PubMed ID: 19397496
[TBL] [Abstract][Full Text] [Related]
3. Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.
Fagerli UM; Ullrich K; Stühmer T; Holien T; Köchert K; Holt RU; Bruland O; Chatterjee M; Nogai H; Lenz G; Shaughnessy JD; Mathas S; Sundan A; Bargou RC; Dörken B; Børset M; Janz M
Oncogene; 2011 Jul; 30(28):3198-206. PubMed ID: 21478911
[TBL] [Abstract][Full Text] [Related]
4. MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway.
Xiao C; Hong H; Yu H; Yuan J; Guo C; Cao H; Li W
Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):278-283. PubMed ID: 29658372
[TBL] [Abstract][Full Text] [Related]
5. Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells.
Pedranzini L; Dechow T; Berishaj M; Comenzo R; Zhou P; Azare J; Bornmann W; Bromberg J
Cancer Res; 2006 Oct; 66(19):9714-21. PubMed ID: 17018630
[TBL] [Abstract][Full Text] [Related]
6. The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells.
Slørdahl TS; Abdollahi P; Vandsemb EN; Rampa C; Misund K; Baranowska KA; Westhrin M; Waage A; Rø TB; Børset M
Oncotarget; 2016 May; 7(19):27295-306. PubMed ID: 27036022
[TBL] [Abstract][Full Text] [Related]
7. The Novel Bromodomain and Extraterminal Domain Inhibitor INCB054329 Induces Vulnerabilities in Myeloma Cells That Inform Rational Combination Strategies.
Stubbs MC; Burn TC; Sparks R; Maduskuie T; Diamond S; Rupar M; Wen X; Volgina A; Zolotarjova N; Waeltz P; Favata M; Jalluri R; Liu H; Liu XM; Li J; Collins R; Falahatpisheh N; Polam P; DiMatteo D; Feldman P; Dostalik V; Thekkat P; Gardiner C; He X; Li Y; Covington M; Wynn R; Ruggeri B; Yeleswaram S; Xue CB; Yao W; Combs AP; Huber R; Hollis G; Scherle P; Liu PCC
Clin Cancer Res; 2019 Jan; 25(1):300-311. PubMed ID: 30206163
[TBL] [Abstract][Full Text] [Related]
8. The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications.
Ogiya D; Liu J; Ohguchi H; Kurata K; Samur MK; Tai YT; Adamia S; Ando K; Hideshima T; Anderson KC
Blood; 2020 Nov; 136(20):2334-2345. PubMed ID: 32844992
[TBL] [Abstract][Full Text] [Related]
9. Selective JAK/STAT3 signalling regulates transcription of colony stimulating factor-2 and -3 in Concanavalin-A-activated mesenchymal stromal cells.
Zgheib A; Pelletier-Bonnier É; Levros LC; Annabi B
Cytokine; 2013 Aug; 63(2):187-93. PubMed ID: 23688618
[TBL] [Abstract][Full Text] [Related]
10. RhoU forms homo-oligomers to regulate cellular responses.
Clayton NS; Hodge RG; Infante E; Alibhai D; Zhou F; Ridley AJ
J Cell Sci; 2024 Jan; 137(2):. PubMed ID: 38180080
[TBL] [Abstract][Full Text] [Related]
11. An activated JAK/STAT3 pathway and CD45 expression are associated with sensitivity to Hsp90 inhibitors in multiple myeloma.
Lin H; Kolosenko I; Björklund AC; Protsyuk D; Österborg A; Grandér D; Tamm KP
Exp Cell Res; 2013 Mar; 319(5):600-11. PubMed ID: 23246572
[TBL] [Abstract][Full Text] [Related]
12. Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma.
Beldi-Ferchiou A; Skouri N; Ben Ali C; Safra I; Abdelkefi A; Ladeb S; Mrad K; Ben Othman T; Ben Ahmed M
PLoS One; 2017; 12(4):e0174835. PubMed ID: 28369102
[TBL] [Abstract][Full Text] [Related]
13. A proto-oncogene BCL6 is up-regulated in the bone marrow microenvironment in multiple myeloma cells.
Hideshima T; Mitsiades C; Ikeda H; Chauhan D; Raje N; Gorgun G; Hideshima H; Munshi NC; Richardson PG; Carrasco DR; Anderson KC
Blood; 2010 May; 115(18):3772-5. PubMed ID: 20228272
[TBL] [Abstract][Full Text] [Related]
14. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
[TBL] [Abstract][Full Text] [Related]
15. Identification of a bipartite focal adhesion localization signal in RhoU/Wrch-1, a Rho family GTPase that regulates cell adhesion and migration.
Ory S; Brazier H; Blangy A
Biol Cell; 2007 Dec; 99(12):701-16. PubMed ID: 17620058
[TBL] [Abstract][Full Text] [Related]
16. The atypical RhoU/Wrch1 Rho GTPase controls cell proliferation and apoptosis in the gut epithelium.
Slaymi C; Vignal E; Crès G; Roux P; Blangy A; Raynaud P; Fort P
Biol Cell; 2019 May; 111(5):121-141. PubMed ID: 30834544
[TBL] [Abstract][Full Text] [Related]
17. Lycorine induces cell death in MM by suppressing Janus Kinase/signal transducer and activator of transcription via inducing the expression of SOCS1.
Jin Z; Zhou S; Zhang Y; Ye H; Jiang S; Yu K; Ma Y
Biomed Pharmacother; 2016 Dec; 84():1645-1653. PubMed ID: 27847203
[TBL] [Abstract][Full Text] [Related]
18. IL-6 up-regulates mcl-1 in human myeloma cells through JAK / STAT rather than ras / MAP kinase pathway.
Puthier D; Bataille R; Amiot M
Eur J Immunol; 1999 Dec; 29(12):3945-50. PubMed ID: 10602002
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
[TBL] [Abstract][Full Text] [Related]
20. Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN.
Heo JY; Kim HJ; Kim SM; Park KR; Park SY; Kim SW; Nam D; Jang HJ; Lee SG; Ahn KS; Kim SH; Shim BS; Choi SH; Ahn KS
Cancer Lett; 2011 Sep; 308(1):71-80. PubMed ID: 21565443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
